Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasmodium Falciparum, Malaria”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02601716
What this trial is testing

PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults

Who this might be right for
Malaria
Sanaria Inc. 92
Not applicableStudy completedNCT00951106
What this trial is testing

Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon

Who this might be right for
Malaria, VivaxMalaria, Falciparum
Walter Reed Army Institute of Research (WRAIR)
Large-scale testing (Phase 3)Study completedNCT00646126
What this trial is testing

Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

Who this might be right for
Plasmodium FalciparumAsymptomatic ParataemiaSub Patent Parasitaemia
Tropical Medicine Research Institute
Large-scale testing (Phase 3)Ended earlyNCT01103063
What this trial is testing

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Who this might be right for
Intermittent Preventive Treatment In Pregnancy (IPTp)
Pfizer 2,891
Large-scale testing (Phase 3)Study completedNCT04147546
What this trial is testing

Additional Screening With Sensitives RDTs and Malaria

Who this might be right for
Plasmodium Falciparum MalariaMalaria Diagnosis
Institut de Recherche en Sciences de la Sante, Burkina Faso 340
Testing effectiveness (Phase 2)Ended earlyNCT02880241
What this trial is testing

MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

Who this might be right for
Malaria
Medicines for Malaria Venture 8
Not applicableStudy completedNCT03172221
What this trial is testing

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

Who this might be right for
Plasmodium FalciparumPregnancy MalariaDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 880
Testing effectiveness (Phase 2)Study completedNCT00459615
What this trial is testing

Phase II Dose Ranging Study of Artesunate

Who this might be right for
Falciparum MalariaUncomplicated Malaria
U.S. Army Office of the Surgeon General 120
Early research (Phase 1)Study completedNCT04310085
What this trial is testing

Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites

Who this might be right for
Malaria,FalciparumParasitemiaProtozoan Infections+1 more
Medicines for Malaria Venture 16
Testing effectiveness (Phase 2)Study completedNCT00460525
What this trial is testing

Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali

Who this might be right for
Plasmodium Falciparum Malaria
U.S. Army Medical Research and Development Command 400
Testing effectiveness (Phase 2)Study completedNCT03521973
What this trial is testing

Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children

Who this might be right for
Malaria
Sanaria Inc. 200
Not applicableStudy completedNCT04766879
What this trial is testing

Spatial Repellents for the Prevention of Malaria in Kenya

Who this might be right for
Malaria
University of Notre Dame 5,984
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05441410
What this trial is testing

Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults

Who this might be right for
Malaria
University Hospital Tuebingen 30
Post-approval studies (Phase 4)Study completedNCT00699920
What this trial is testing

Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Who this might be right for
Malaria
Sanofi 413
Early research (Phase 1)Study completedNCT02313376
What this trial is testing

Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes

Who this might be right for
Malaria
Seattle Children's Hospital 10
Early research (Phase 1)Looking for participantsNCT07670377
What this trial is testing

Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 20
Large-scale testing (Phase 3)Study completedNCT00379821
What this trial is testing

Chloroquine Alone or in Combination for Malaria in Children in Malawi

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 640
Testing effectiveness (Phase 2)Looking for participantsNCT05750628
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 327
Post-approval studies (Phase 4)UnknownNCT01075945
What this trial is testing

Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan

Who this might be right for
Malaria
University of Khartoum 140
Early research (Phase 1)Study completedNCT00358332
What this trial is testing

Phase I Pediatric FMP2.1/AS02A Trial in Mali

Who this might be right for
Plasmodium Falciparum Malaria
U.S. Army Medical Research and Development Command 100
Next Page